Disease, 2016, an estimated around 251 million cases of COPD were reported worldwide.
According to the World Health Organization (WHO), 2015, an estimated 3.17 million deaths were
caused by the disease accounting for 5% of all deaths. However, lack of awareness regarding the
diseases harmful effects of certain respiratory care devices on neonates are the factors restraining
respiratory devices market growth.
Increasing admissions of critical care patients in Intensive Care Units (ICU) is expected to fuel
the market growth
Increasing prevalence of chronic respiratory diseases such as asthma, chronic pulmonary lung
disease, pulmonary hypertension, and occupational lung disease are the major factors augmenting
growth of the respiratory devices market, owing to the pronounced need of therapeutic respiratory
devices in the medical as well as in the homecare settings. According to the World Health
Organization (WHO), in 2017, asthma is a major non communicable disease with an estimated 235
million people suffering from the condition. According to the American Academy of Allergy
Asthma and Immunology, 2015, an estimated number of people suffering from asthma is expected
to increase by more than 100 million by 2025. North America is expected to dominate the
respiratory devices market, owing to increasing number of hospitalizations and emergency visits
associated with acute or life threatening medical problems. According to the study by Society of
Critical Care Medicine 2016, more than 5.7 million patients are admitted annually to intensive care
units (ICUs) in the U.S. for support of airway, breathing or circulation, and comprehensive
management of injury. Also, According to the Centers of Disease Control and Prevention (CDC),
2017, around 1.7 million emergency department visits with chronic and unspecified bronchitis were
registered in the U.S. hospital facilities. However, stringent FDA approvals, lack of awareness about
innovative devices and unaffordable or high cost of respiratory devices are the factors restraining
growth of the respiratory devices market.
For More Information @
https://www.coherentmarketinsights.com/market-insight/respiratory-devices-market-1299
Increasing support from international organizations for prevention of chronic respiratory
diseases is expected to accelerate the market growth
Various organizations, institutions, and agencies are working towards improving the diagnosis and
the medical care needed to reduce the global burden of respiratory diseases. For instance, the Global
Alliance against Chronic Respiratory Diseases (GARD) was formed with the support from the
World Health Organization (WHO) to control chronic respiratory diseases. GARD is a voluntary
alliance of national, international organizations, and agencies from many economies. The main
objective of GARD is to develop simple and affordable strategies for chronic respiratory diseases
(CRD) and to encourage economies to implement health promotion and CRD prevention policies.
Also, increasing birth defects such as newborn respiratory distress syndrome, cyanosis, and
Broncho-pulmonary dysplasia requires the need for neonate/pediatric respiratory devices to increase
the survival chances of infants. According to the Centers of Disease Control and Prevention (CDC),
an estimate of 1.5 million babies were born with birth defects with about one quarter primary
consultations related to respiratory complaints.
Request For Customization @ https://www.coherentmarketinsights.com/insight/request-
customization/1299
Global Key players: